Merck & Company, Inc. Press Releases

MRK 
$55.51
*  
0.38
0.69%
Get MRK Alerts
*Delayed - data as of Oct. 22, 2014  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Merck’s Investigational Beta-lactamase Inhibitor Relebactam (MK-7655) Granted Qualified Infectious Disease Product (QIDP) and Fast Track Designations by FDA
9/4/2014 9:00:00 AM - Business Wire


Merck to Present New Data in Five Tumor Types from Studies Evaluating Pembrolizumab, the Company’s Investigational Anti-PD-1 Antibody, at ESMO 2014
9/2/2014 8:30:00 AM - Business Wire


Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
8/26/2014 8:00:00 AM - Business Wire


Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal
8/15/2014 9:00:00 AM - PR Newswire


Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals
8/14/2014 9:00:00 AM - PR Newswire


Merck Statement regarding Role of PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) in Updated ACIP Recommendations for Pneumococcal Vaccination in Adults
8/13/2014 5:58:00 PM - Business Wire


FDA Approves BELSOMRA® (suvorexant) for the Treatment of Insomnia
8/13/2014 4:49:00 PM - Business Wire


Boston Millennia Partners Liquidity Events Realize More Than $100 Million of Value for its Limited Partners
8/6/2014 3:13:00 PM - Business Wire


Merck Publishes 2013 Global Corporate Responsibility Report
8/5/2014 1:00:00 PM - Business Wire


Merck Completes Tender Offer to Acquire Idenix
8/5/2014 6:00:00 AM - Business Wire


Merck Announces Second-Quarter 2014 Financial Results
7/29/2014 6:56:00 AM - Business Wire